ArticleBreast cancer research : BCR2019

Combining the oncolytic peptide LTX-315 with doxorubicin demonstrates therapeutic potential in a triple-negative breast cancer model.

Ketil A Camilio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.